Impact of sodium-glucose co-transporter 2 inhibitors on renal outcomes in patients of diabetes mellitus: A meta-analysis of landmark renal and cardiovascular outcome trials

Sodium-glucose co-transporter 2 inhibitors (SGLT2is) are recommended as the next step therapy for the management of diabetes mellitus. The large clinical trials of SGLT2is demonstrated benefits on various renal endpoints. We conducted this meta-analysis of large trials on cardiovascular and renal sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bose, Debdipta, Maurya, Miteshkumar, Konwar, Mahanjit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335648/
https://www.ncbi.nlm.nih.gov/pubmed/37313937
http://dx.doi.org/10.4103/ijp.ijp_342_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335648/
https://www.ncbi.nlm.nih.gov/pubmed/37313937
http://dx.doi.org/10.4103/ijp.ijp_342_21

Ejemplares similares